We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Stratasys (SSYS) Completes Origin Buyout to Fuel 3D Printing
Read MoreHide Full Article
Stratasys (SSYS - Free Report) announced that it has recently completed the previously announced acquisition of Origin, a San Francisco-based 3D printing start-up.
On Dec 9, 2020, the company entered into an agreement to acquire Origin in a cash-and-stock deal worth $100 million. The buyout has been funded with $55 million in cash and $45 million in stock. Stratasys has paid $60 million upfront and the remaining $40 million will be paid as performance-based earnouts over the next three years.
Notably, the company benefits from Origin’s proprietary resin-based Programmable PhotoPolymerization technology used in its manufacturing-grade 3D printer, Origin One. Moreover, the integration of Origin’s software-centric additive manufacturing solution helps Stratasys gain a competitive edge in the 3D-printed mass production parts market.
Additionally, the technology is expected to generate incremental annual revenues of $200 million within five years. Moreover, the acquisition is anticipated to be accretive to non-GAAP earnings growth by 2023, although it might have a dilutive effect on 2021 non-GAAP earnings.
Growing Product Portfolio to Fend Off Pandemic Woes
Stratasys’ shares have gained 3.9% over the past year compared with the Zacks Computer - Peripheral Equipment industry’s growth of 57.7%.
Notably, the company’s continuous initiatives to fortify its position in the 3D printing space by adding new capabilities to its 3D printing portfolio are a major growth driver.
In December 2020, Stratasys introduced several new product capabilities to aid 3D printing. It launched its application programming interface (API) program, which facilitates API connectivity between its Fused Deposition Modeling (FDM) 3D printers and enterprise software applications, using the GrabCAD Software Development Kit (SDK).
Moreover, the addition of three new Kimya ABS composite materials to MakerBot’s METHOD 3D printers, which boosts the performance of METHOD printers, is a major positive. Furthermore, the company introduced ultra-realistic simulation and realism with advanced bone capabilities to its J750 Digital Anatomy 3D printer.
However, the company’s top line was adversely impacted by pandemic-induced weakened demand for its hardware and consumables in the third quarter of 2020. Its product revenues decreased 21.4% year over year to $83.5 million.
Nevertheless, the expansion of Stratasys’ robust 3D printing portfolio along with the recent acquisition of Origin is expected to drive customer acquisition for the company, thereby boosting its growth prospects in the near term.
Long-term earnings growth rate for 3D Systems, PerkinElmer and Broadcom is currently pegged at 26%, 19.5% and 12.9%, respectively.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
Image: Bigstock
Stratasys (SSYS) Completes Origin Buyout to Fuel 3D Printing
Stratasys (SSYS - Free Report) announced that it has recently completed the previously announced acquisition of Origin, a San Francisco-based 3D printing start-up.
On Dec 9, 2020, the company entered into an agreement to acquire Origin in a cash-and-stock deal worth $100 million. The buyout has been funded with $55 million in cash and $45 million in stock. Stratasys has paid $60 million upfront and the remaining $40 million will be paid as performance-based earnouts over the next three years.
Notably, the company benefits from Origin’s proprietary resin-based Programmable PhotoPolymerization technology used in its manufacturing-grade 3D printer, Origin One. Moreover, the integration of Origin’s software-centric additive manufacturing solution helps Stratasys gain a competitive edge in the 3D-printed mass production parts market.
Additionally, the technology is expected to generate incremental annual revenues of $200 million within five years. Moreover, the acquisition is anticipated to be accretive to non-GAAP earnings growth by 2023, although it might have a dilutive effect on 2021 non-GAAP earnings.
Growing Product Portfolio to Fend Off Pandemic Woes
Stratasys’ shares have gained 3.9% over the past year compared with the Zacks Computer - Peripheral Equipment industry’s growth of 57.7%.
Stratasys, Ltd. Price and Consensus
Stratasys, Ltd. price-consensus-chart | Stratasys, Ltd. Quote
Notably, the company’s continuous initiatives to fortify its position in the 3D printing space by adding new capabilities to its 3D printing portfolio are a major growth driver.
In December 2020, Stratasys introduced several new product capabilities to aid 3D printing. It launched its application programming interface (API) program, which facilitates API connectivity between its Fused Deposition Modeling (FDM) 3D printers and enterprise software applications, using the GrabCAD Software Development Kit (SDK).
Moreover, the addition of three new Kimya ABS composite materials to MakerBot’s METHOD 3D printers, which boosts the performance of METHOD printers, is a major positive. Furthermore, the company introduced ultra-realistic simulation and realism with advanced bone capabilities to its J750 Digital Anatomy 3D printer.
However, the company’s top line was adversely impacted by pandemic-induced weakened demand for its hardware and consumables in the third quarter of 2020. Its product revenues decreased 21.4% year over year to $83.5 million.
Nevertheless, the expansion of Stratasys’ robust 3D printing portfolio along with the recent acquisition of Origin is expected to drive customer acquisition for the company, thereby boosting its growth prospects in the near term.
Zacks Rank & Stocks to Consider
Stratasys currently has a Zacks Rank #4 (Sell).
Some better-ranked stocks in the broader technology sector are PerkinElmer , 3D Systems (DDD - Free Report) and Broadcom (AVGO - Free Report) . PerkinElmer sports a Zacks Rank #1 (Strong Buy), while 3D Systems and Broadcom carry a Zacks Rank #2 (Buy), at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
Long-term earnings growth rate for 3D Systems, PerkinElmer and Broadcom is currently pegged at 26%, 19.5% and 12.9%, respectively.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>